News

ARTAN Bio Advances Therapeutics with Innovative Syenex Partnership

ARTAN Bio Advances Therapeutics with Innovative Syenex Partnership

ARTAN Bio Partners with Syenex for Advanced Therapeutic Delivery

ARTAN Bio, an innovative biotechnology company, has partnered with Syenex, which specializes in genetic medicines. This collaboration aims to utilize Syenex's VivoCell Platform to enhance the precision delivery of ARTAN's leading therapeutic candidate, ARTAN-102. ARTAN Bio is committed to developing treatments that reverse the epigenetic changes associated with aging and age-related diseases.

Strategic Collaboration Highlights

Under their agreement, ARTAN Bio will gain access to the advanced VivoCell Platform from Syenex. This access is crucial as it supports the creation of tailored delivery vehicles specifically designed for ARTAN's codon suppressor platform. This collaboration emphasizes a shared goal to expedite ARTAN's timeline from initial in vitro proof-of-concept to investigational new drug (IND) enabling studies, ensuring a cost-efficient approach.

Leadership Insights

Dr. Michael Torres, Co-Founder and Chief Scientific Officer of ARTAN Bio, expressed enthusiasm about the partnership, stating that precise and efficient delivery is vital for realizing the full potential of ARTAN-102. He highlighted Syenex’s proven expertise in delivery vehicle innovation, positioning them as an ideal collaboration partner. Similarly, Jay Rosanelli, Chief Executive Officer of Syenex, noted ARTAN Bio's compelling preclinical evidence pointing to the therapeutic promise of ARTAN-102. The integration of ARTAN's technology with Syenex's VivoCell capabilities aims to streamline development phases and expand treatment possibilities for aging-related conditions.

Key Aspects of Collaboration

The collaboration outlines several key operational aspects that will drive their efforts forward:

  • Rapid Prototyping: Access is granted to the full spectrum of the VivoCell Platform, which includes an array of precision delivery components supported by Syenex's pre-clinical prototyping and production services.
  • Manufacturing Scale-Up: Once prototypes are developed, they will transition to Syenex's Contract Development and Manufacturing Organization (CDMO) partner for Good Manufacturing Practices (GMP) scale-up.
  • Option Rights: ARTAN has a non-exclusive program license option covering the clinical delivery vehicle composition.

The financial details regarding this collaboration have not been made public.

About ARTAN Bio

ARTAN Bio is at the forefront of developing first-in-class therapeutics aimed at restoring the functionality of proteins that are vital in combating aging and age-related diseases. Backed by a decentralized scientific community committed to expediting cures, ARTAN Bio is revolutionizing the approach to age-related health challenges.

About Syenex

Syenex is known for its open-science approach in biotechnology, focusing on the precise programming of cells at scale. The company utilizes synthetic biology frameworks to support genetic medicine developers, enabling rapid advancement from discovery to clinical implementation. Founded in 2022, Syenex has forged numerous partnerships across the healthcare landscape, thereby enhancing its delivery technologies for both ex vivo and in vivo applications.

Frequently Asked Questions

What is the main goal of the ARTAN Bio and Syenex partnership?

The primary goal of the collaboration is to utilize Syenex's VivoCell Platform to enhance the in vivo delivery of ARTAN's lead therapeutic candidate, ARTAN-102, ensuring a more effective treatment process.

How does the VivoCell Platform benefit ARTAN Bio?

The VivoCell Platform provides ARTAN Bio with advanced precision delivery technologies that are specifically tailored to their codon suppressor platform, thus enabling improved therapeutic outcomes.

Who are the key figures behind ARTAN Bio?

Dr. Michael Torres serves as the Co-Founder and Chief Scientific Officer, emphasizing the importance of precise delivery systems in optimizing therapeutic potential.

What technologies does Syenex use in its operations?

Syenex leverages synthetic biology and a network of manufacturing organizations to provide comprehensive delivery solutions for genetic medicine developers.

When was Syenex founded?

Syenex was founded in 2022 and has since developed a robust portfolio of cell-specific delivery technologies and partnerships within the biopharma industry.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Skiptown Expands into Austin: A New Pet Care Frontier

Updated Category News Views 0

Skiptown Marches into the Heart of Texas A move into Texas? Now that's got potential written all over it. Skiptown's making waves by dropping anchor in Austin with a five-unit franchise agreement. We're talking modern dog daycare and more, right in the heart of Central Texas. First up, fall 2027 is when you can circle the calendar. Expect to see more locations sprout up...

Continue Reading
Pathology Ventures: Industry Veteran Takes the Helm

Updated Category News Views 0

What's Brewing with Pathology Ventures? Amidst the bustling landscape of healthcare, Pathology Ventures, LLC shakes things up by appointing Dominic Stockey as their Executive Vice President. Now, buckle up because Stockey isn’t your average Joe. He’s kicking it up a notch by spearheading sponsor and industry partnerships at this physician-founded network. His turf?...

Continue Reading
El Mansouri Becomes Morocco's First Female PM

Updated Category News Views 0

Breaking Barriers: El Mansouri's Historic Appointment Fatima Ezzahra El Mansouri is now steering the ship as Morocco's first female Prime Minister, a milestone that's taken far too long to reach. After the dust settled from the September 23 legislative elections, El Mansouri emerged from the Authenticity and Modernity Party (PAM) with 97 seats in tow. It's a pivotal...

Continue Reading
Joe Richardson's Impact Reaches New Heights in 2026

Updated Category News Views 0

They don't hand out "Attorney of the Year" awards to just anyone. Joe Richardson snagged this title from the Richard T. Fields Bar Association not just because he's part of McCune Law Group, but because he's been shaking up the legal arena with his advocacy and leadership. Let's peel back why this matters not only within his circles but for the broader legal community...

Continue Reading
Oak Farms Invests in Texas Schools and Students

Updated Category News Views 2

Putting Money Where Their Roots Are You have to hand it to Oak Farms; when they say they're rooted in Texas, they actually back it up with some cold, hard cash. They've lined up $27,500 for schools and students across the state. That's the kind of talking I like to see—straight from the brand to the community ledger. No fluff, just good old-fashioned giving in the form...

Continue Reading
Kohler's Golf Innovation: No Tees Tour Comes Alive

Updated Category News Views 0

Golf Reinvented: Kohler Hosts No Tees Tour Talk about flipping the script, eh? Kohler's teaming up with the No Tees Tour to host an innovative golfing showdown at The Baths of Blackwolf Run, starting October 1. This isn't your grandpa's golf tour. We're talking fast-paced, head-to-head chipping duels that ditch the long drives for surgical precision. The idea's inspired...

Continue Reading
Virginia's 3D Printing Push: Affordable Housing Revolution

Updated Category News Views 0

Pioneering Affordable Homes with 3D Printing There’s something brewing in Henrico County that’s got the potential to shake up the entire construction industry: 3D printing. Now, hold your horses if you think this isn’t about stock tickers flashing green or red. Sometimes it’s just about reimagining what living affordable means. With Richmond Metropolitan Habitat...

Continue Reading
Cytrellis Expands with ellacor to South Korean Market

Updated Category News Views 1

Diving Headfirst into a Prosperous Market Imagine a company looking to break through the global market, and you've got Cytrellis Biosystems on the brink of a full-blown success story. Today, they're making waves with their latest move in the booming South Korean aesthetic market. With an agreement with KoreAx Co. Ltd., they've officially set their sights on bringing the...

Continue Reading
Survey Says 92% Report Better Life Post-Rehab

Updated Category News Views 2

92% Say Life Improves After TranquilHearts' Treatment It's not every day you see 92% of folks claiming something actually worked for them, huh? That's exactly the kind of figure TranquilHearts Rehab's alumni claimed in their recent survey about improved quality of life post-treatment. But let's not get ahead of ourselves with high-fives and celebration just yet. Here's...

Continue Reading
Fitness Connection Plots New Facility at CityNorth Park

Updated Category News Views 0

Alright, folks, let's talk Fitness Connection and their fresh move that's shaking things up in North Houston. So, they're not just sticking around; they're tuning up a beefy new 45,000-square-foot club right where Greenspoint Mall once stood. There's a $150 million overhaul going on at this site now known as CityNorth, and Fitness Connection plans to be right at the heart...

Continue Reading

Top 5 Most Recently Viewed Articles

St. Thomas University College of Law Achieves ABA Accreditation

Updated Category News Views 109

St. Thomas University College of Law Celebrates ABA Accreditation St. Thomas University (STU) proudly announces that the American Bar Association (ABA) Council has recognized the STU College of Law as fully compliant with essential accreditation standards. This significant achievement demonstrates the university's unwavering dedication to maintaining the highest level of...

Continue Reading
Explore the Best Performing Mid-Cap Stocks of 2024

Updated Category News Views 1078

The Surge of Mid-Cap Stocks in the Market Mid-cap stocks are emerging strongly in the market, showcasing an impressive growth of approximately 12% year-to-date. This often-overlooked segment of the market has proven to be a performance leader over time, noticeably returning excellent gains for investors. While large-cap selections gain most of the spotlight and small-cap...

Continue Reading
BellRing Brands (NYSE: BRBR) Faces Investigation Over Fraud Claims

Updated Category News Views 123

BellRing Brands Under Investigation Recently, it has come to light that BellRing Brands, Inc. (NYSE: BRBR) is facing an intense investigation concerning potential securities fraud. This inquiry is spearheaded by the prominent securities law firm Bleichmar Fonti & Auld LLP, which is examining the company for possible violations of federal securities laws. For those who...

Continue Reading
U.S. Steel Challenges Biden’s Block of Acquisition Deal

Updated Category News Views 187

U.S. Steel's Legal Challenge Against Biden's Acquisition Block United States Steel Corporation (NYSE: X) and Nippon Steel Corp have launched a lawsuit contesting President Biden's recent decision to block their acquisition deal. The lawsuit argues that such action infringes upon constitutional guarantees of due process, thereby raising significant legal questions about...

Continue Reading
Valneva Reports on Share and Voting Rights Status Update

Updated Category News Views 56

Valneva's Update on Shares and Voting Rights VALNEVA Declaration of Shares and Voting Rights Company name: VALNEVA Registered office: 6 rue Alain Bombard, 44800 Saint-Herblain This report aims to keep stakeholders informed about the current state of the company’s share capital and voting rights. Valneva prioritizes transparency and routinely updates its shareholders on...

Continue Reading